The U.S. acellular dermal matrices market consists of sterile tissue matrices derived from human or animal dermis that acts as a scaffold for tissue regeneration. These matrices find widespread applications in various soft tissue repair procedures such as breast reconstruction, hernia repair, abdominal wall defects, facial defects, among others. The increasing prevalence of diabetic foot ulcers and burns along with growing geriatric population suffering from chronic wounds is driving the demand for advanced wound care solutions.

The U.S. Acellular Dermal Matrices Market Is Estimated To Be Valued At US$ 3206.39 Mn In 2024 And Is Expected To Exhibit A CAGR Of 5.8% over the forecast period 2024 to 2031.


The outbreak of COVID-19 pandemic has significantly impacted the growth of U.S. acellular dermal matrices market. During the early stages, elective and non-essential surgical procedures were put on hold or postponed due to lockdowns and restricted hospital resources. This resulted in decline in demand for acellular dermal matrices, which are mainly used for hernia repair and breast reconstruction surgeries. Manufacturers faced challenges in raw material procurement and production disruptions led to supply shortages. However, with resumption of operations post lockdowns and prioritizing of delayed treatments, the demand is recovering gradually. The post-COVID scenario is expected to witness steady growth demand backed by increasing cases of breast cancer and rising obese population leading to hernia cases. Manufacturers are enhancing production capacities and supply chain resilience to ensure continuous supply. Hospitals are adopting stringent safety protocols to assure patients for elective treatments. Ongoing research on development of acellular dermal matrices using advanced technologies will further support market growth in coming years.

Get more insights on U.S. Acellular Dermal Matrices Market Growth